Sahar is a 2nd year Biochemistry major at UCLA. She joined the Conway Group in June 2026 and is working on the development of an EPAC2 inhibitor to combat Fragile X Syndrome. Outside of lab, she loves volleyball, playing piano, board games, and spending time with friends and family.